A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)
Condition:   Asthma Interventions:   Drug: Zero-dose;   Drug: 90 mcg of PROAIR® HFA;   Drug: 180 mcg of 90 mcg of PROAIR® HFA;   Drug: 90 mcg of albuterol sulfate inhalation aerosol Sponsor:   Sun Pharmaceutical Industries Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD
Condition:   COPD Interventions:   Combination Product: Albuterol Sulfate and Ipratropium Bromide;   Combination Product: Albuterol Sulfate Sponsor:   Pneuma Respiratory, Inc Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: budesonide/formoterol;   Drug: albuterol/salbutamol;   Drug: FF/UMEC/VI;   Drug: Placebo to match budesonide/formoterol;   Drug: tiotropium;   Drug: Placebo to match FF/UMEC/VI;   Drug: placebo to match tiotropium;   Device: ELLIPTA;   Device: MDI;   Device: Han diHaler Sponsors:   GlaxoSmithKline;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2018 Category: Research Source Type: clinical trials